Ticker	Volume	Price	Price Delta
DJIA	15,409.10	+73.84	0.48%
S&P 500	1,673.42	+7.13	0.43%
Nasdaq	3,505.36	+8.93	0.26%

Ticker

Volume

Price

Price Delta

DJIA

15,409.10

+73.84

0.48%

S&P 500

1,673.42

+7.13

0.43%

Nasdaq

3,505.36

+8.93

0.26%

Ticker	Volume	Price	Price Delta
STOXX 50	2,821.65	-2.85	-0.10%
FTSE 100	6,803.87	+48.24	0.71%
DAX	8,472.20	+16.37	0.19%

Ticker

Volume

Price

Price Delta

STOXX 50

2,821.65

-2.85

-0.10%

FTSE 100

6,803.87

+48.24

0.71%

DAX

8,472.20

+16.37

0.19%

Ticker	Volume	Price	Price Delta
Nikkei	15,381.00	+20.21	0.13%
Hang Seng	23,366.40	-126.66	-0.54%
S&P/ASX 200	5,180.06	-28.98	-0.56%

Ticker

Volume

Price

Price Delta

Nikkei

15,381.00

+20.21

0.13%

Hang Seng

23,366.40

-126.66

-0.54%

S&P/ASX 200

5,180.06

-28.98

-0.56%

Exchange: Xetra
Sector: Consumer, Non-cyclical
Industry: Healthcare-Products
Sub-Industry: Diagnostic Kits

QIAGEN NV

+ Add to Watchlist

QIA:GR

14.405 EUR 0.045 0.31%

Share this quote:

Post this quote on one of these sites:

Copy permanent URL

As of 11:51:41 ET on 05/21/2013.

Snapshot for QIAGEN NV (QIA)

Open:	14.465	Day's Range:	14.380 - 14.525	Volume:	330,161
Previous Close:	14.450	52wk Range:	11.820 - 16.765	1-Yr Rtn:	+10.64%

Stock Chart for QIA

No chart data available.

QIA:GR 14.405

14.450

Interactive QIA Chart

…

Previous Close

Key Statistics for QIA

Current P/E Ratio (ttm)	24.1499
Estimated P/E(12/2013)	16.9732
Relative P/E vs. DAX	1.4766
Earnings Per Share (USD) (ttm)	0.7700
Est. EPS (USD) (12/2013)	1.0960
Est. PEG Ratio	1.5178
Market Cap (M EUR)	3,440.95
Shares Outstanding (M)	238.87
30 Day Average Volume	513,898
Price/Book (mrq)	1.6190
Price/Sale (ttm)	3.5185
Dividend Indicated Gross Yield	-%
Cash Dividend	-
Last Dividend
5 Year Dividend Growth	-
Next Earnings Announcement	07/24/2013

mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for QIA

Revenue
Net Income (M/USD)

Profit Margin (%)

Company Profile & Key Executives for QIA

QIAGEN N.V. provides sample and assay technologies. The Company's technologies (in the format of consumables and automated solutions) are used to process biological samples and to analyze analytes contained therein, such as DNA and RNA. QIAGEN provides these technologies to customers conducting molecular diagnostics, applied testing, pharmaceutical R&D and academic research.